Rain Oncology Inc.
DelistedCIK 1724979fmd_16R145XB351R7G7JSWM11P5A44Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2023, 15 periods
| Line item | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| Realized investment gains (losses) | – | 0 | 0 |
| Research and development | 15 | 41 | 61 |
| Total operating expenses | 19 | 52 | 77 |
| Operating income | (19) | (52) | (77) |
| Interest expense | 0 | – | – |
| Interest and investment income | 0 | 0 | 1 |
| Other non-operating income (expense) | (2) | 0 | 1 |
| Income before taxes | (21) | (51) | (76) |
| Income tax expense | – | 0 | 0 |
| Net income from continuing operations | – | (51) | (76) |
| Net income | (21) | (51) | (76) |